ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD

The Phase IV, 8-week, randomized, double-blind, placebo-controlled ACTIVATE study (NCT02424344) evaluated the effect of aclidinium/formoterol (AB/FF) 400/12 μg twice daily on lung hyperinflation, exercise capacity, and physical activity in patients with moderate-to-severe COPD. Patients received AB/...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Chron Obstruct Pulmon Dis
Hoofdauteurs: Watz, Henrik, Troosters, Thierry, Beeh, Kai M, Garcia-Aymerich, Judith, Paggiaro, Pierluigi, Molins, Eduard, Notari, Massimo, Zapata, Antonio, Jarreta, Diana, Garcia Gil, Esther
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2017
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5574699/
https://ncbi.nlm.nih.gov/pubmed/28883722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S143488
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items